ANCA-Associated Vasculitis

被引:1
作者
Sharma, Purva [1 ]
Zonozi, Reza [2 ,3 ]
Geetha, Duvuru [4 ]
机构
[1] Northwell Hlth, Glomerular Ctr, Div Kidney Dis & Hypertens, Great Neck, NY USA
[2] Nephrol Associates Northern Virginia, Fairfax, VA USA
[3] Inova Fairfax Hosp, Falls Church, VA USA
[4] Johns Hopkins Univ, Sch Med, Div Nephrol, Baltimore, MD USA
来源
ADVANCES IN KIDNEY DISEASE AND HEALTH | 2024年 / 31卷 / 03期
关键词
ANCA; Rituximab; Plasmapheresis; Vasculitis; ANTIBODY-ASSOCIATED VASCULITIS; RHEUMATOLOGY CLASSIFICATION CRITERIA; 2022; AMERICAN-COLLEGE; ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; DAILY ORAL CYCLOPHOSPHAMIDE; RANDOMIZED-TRIAL; PLASMA-EXCHANGE; RENAL SURVIVAL; CRESCENTIC GLOMERULONEPHRITIS; WEGENERS-GRANULOMATOSIS;
D O I
10.1053/j.akdh.2024.04.005
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
ANCA-associated vasculitis (AAV) is a necrotizing, small-to-medium vessel vasculitis associated with significant morbidity and mortality. AAV is a systemic autoimmune disease affecting kidneys, eyes, sinuses, peripheral nerves, skin, and upper and lower respiratory tracts. AAV tends to present in characteristic phenotypes categorized clinically as granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic GPA (EGPA). Kidney involvement is a common feature of AAV, and has important implications on disease prognosis and management. Existing therapies have been refined and improvements in our understanding of the pathophysiology of AAV has led to approval of novel therapies. In this review, we provide an overview of epidemiology, disease mechanisms, clinical presentation and review therapeutic strategies for induction and maintenance of remission.
引用
收藏
页码:194 / 205
页数:12
相关论文
共 97 条
  • [1] Ahmad Youssef K, 2017, Hosp Pharm, V52, P294, DOI 10.1310/hpj5204-294
  • [2] Outcomes of remission induction therapy for ANCA-associated vasculitis in the elderly
    Aqeel, Faten
    Xu, Lillian
    Salas, Antonio
    Wen, Yumeng
    Eid, Shaker M.
    Geetha, Duvuru
    [J]. CLINICAL RHEUMATOLOGY, 2023, 42 (09) : 2427 - 2435
  • [3] Asakawa Tomohiko, 2020, Case Rep Nephrol, V2020, P6343521, DOI 10.1155/2020/6343521
  • [4] Tubular Lesions Predict Renal Outcome in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis after Rituximab Therapy
    Berden, Annelies E.
    Jones, Rachel B.
    Erasmus, Dianhdra D.
    Walsh, Michael
    Noel, Laure-Helene
    Ferrario, Franco
    Waldherr, Ruediger
    Bruijn, Jan A.
    Jayne, David R.
    Bajema, Ingeborg M.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (02): : 313 - 321
  • [5] Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: a systematic review and meta-analysis
    Berti, Alvise
    Alsawas, Mouaz
    Jawaid, Tabinda
    Prokop, Larry J.
    Lee, Jiwon M.
    Jeong, Gwang Hun
    Quintana, Luis F.
    Moiseev, Sergey
    Vaglio, August
    Tesar, Vladimir
    Geetha, Duvuru
    Shin, Jae Il
    Kronbichler, Andreas
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (11) : 2190 - 2200
  • [6] D-penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease
    Bienaime, Frank
    Clerbaux, Gaetan
    Plaisier, Emmanuelle
    Mougenot, Beatrice
    Ronco, Pierre
    Rougier, Jean-Philippe
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 50 (05) : 821 - 825
  • [7] Bir K, 2006, J RHEUMATOL, V33, P185
  • [8] DRB1*15 Allele Is a Risk Factor for PR3-ANCA Disease in African Americans
    Cao, Yali
    Schmitz, John L.
    Yang, Jiajin
    Hogan, Susan L.
    Bunch, Donna
    Hu, Yichun
    Jennette, Caroline E.
    Berg, Elisabeth A.
    Arnett, Frank C., Jr.
    Jennette, J. Charles
    Falk, Ronald J.
    Preston, Gloria A.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (06): : 1161 - 1167
  • [9] Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis A Randomized Trial
    Charles, Pierre
    Perrodeau, Elodie
    Samson, Maxime
    Bonnotte, Bernard
    Neel, Antoine
    Agard, Christian
    Huart, Antoine
    Karras, Alexandre
    Lifermann, Francois
    Godmer, Pascal
    Cohen, Pascal
    Hanrotel-Saliou, Catherine
    Martin-Silva, Nicolas
    Pugnet, Gregory
    Maurier, Francois
    Sibilia, Jean
    Carron, Pierre-Louis
    Gobert, Pierre
    Meaux-Ruault, Nadine
    Le Gallou, Thomas
    Vinzio, Stephane
    Viallard, Jean-Francois
    Hachulla, Eric
    Vinter, Christine
    Puechal, Xavier
    Terrier, Benjamin
    Ravaud, Philippe
    Mouthon, Luc
    Guillevin, Loic
    [J]. ANNALS OF INTERNAL MEDICINE, 2020, 173 (03) : 179 - +
  • [10] Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)
    Charles, Pierre
    Terrier, Benjamin
    Perrodeau, Elodie
    Cohen, Pascal
    Faguer, Stanislas
    Huart, Antoine
    Hamidou, Mohamed
    Agard, Christian
    Bonnotte, Bernard
    Samson, Maxime
    Karras, Alexandre
    Jourde-Chiche, Noemie
    Lifermann, Francois
    Gobert, Pierre
    Hanrotel-Saliou, Catherine
    Godmer, Pascal
    Martin-Silva, Nicolas
    Pugnet, Gregory
    Matignon, Marie
    Aumaitre, Olivier
    Viallard, Jean-Francois
    Maurier, Francois
    Meaux-Ruault, Nadine
    Riviere, Sophie
    Sibilia, Jean
    Puechal, Xavier
    Ravaud, Philippe
    Mouthon, Luc
    Guillevin, Loic
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (08) : 1144 - 1150